Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Frontiers in Immunology
|
April 2, 2026
IFNγ-induced antigen loss in chimeric antigen receptor-T cell therapy
Miao Cao, Jasmine Alvarez, Ramkrishna Mitra, et al.
The Journal of Clinical Investigation
|
December 22, 2022
Intestinal neuropod cell GUCY2C regulates visceral pain
Joshua R Barton, Annie K Londregan, Tyler D Alexander, et al.
Cancer Immunology Research
|
April 5, 2018
Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
Michael S Magee, Tara S Abraham, Trevor R Baybutt, et al.
Cancer Research
|
April 9, 2009
Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease
Adam E Snook, Peng Li, Benjamin J Stafford, et al.
Cancer Research
|
October 3, 2013
Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer
Ahmara V Gibbons, Jieru E Lin, Gilbert W Kim, et al.
NPJ Vaccines
|
June 23, 2022
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
John C Flickinger, Ross E Staudt, Jagmohan Singh, et al.
Infection and Immunity
|
August 3, 2016
Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins
Amanda M Pattison, Erik S Blomain, Dante J Merlino, et al.
Journal of the National Cancer Institute
|
June 26, 2008
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity
Adam E Snook, Benjamin J Stafford, Peng Li, et al.
Cancer Research
|
January 17, 2016
Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis
Jieru E Lin, Francheska Colon-Gonzalez, Erik Blomain, et al.
Journal for Immunotherapy of Cancer
|
August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
John C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Frontiers in Immunology
|
April 2, 2026
IFNγ-induced antigen loss in chimeric antigen receptor-T cell therapy
Miao Cao, Jasmine Alvarez, Ramkrishna Mitra, et al.
The Journal of Clinical Investigation
|
December 22, 2022
Intestinal neuropod cell GUCY2C regulates visceral pain
Joshua R Barton, Annie K Londregan, Tyler D Alexander, et al.
Cancer Immunology Research
|
April 5, 2018
Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
Michael S Magee, Tara S Abraham, Trevor R Baybutt, et al.
Cancer Research
|
April 9, 2009
Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease
Adam E Snook, Peng Li, Benjamin J Stafford, et al.
Cancer Research
|
October 3, 2013
Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer
Ahmara V Gibbons, Jieru E Lin, Gilbert W Kim, et al.
NPJ Vaccines
|
June 23, 2022
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
John C Flickinger, Ross E Staudt, Jagmohan Singh, et al.
Infection and Immunity
|
August 3, 2016
Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins
Amanda M Pattison, Erik S Blomain, Dante J Merlino, et al.
Journal of the National Cancer Institute
|
June 26, 2008
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity
Adam E Snook, Benjamin J Stafford, Peng Li, et al.
Cancer Research
|
January 17, 2016
Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis
Jieru E Lin, Francheska Colon-Gonzalez, Erik Blomain, et al.
Journal for Immunotherapy of Cancer
|
August 22, 2020
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
John C Flickinger, Jagmohan Singh, Robert Carlson, et al.
Page
of 10